Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor

Details for Australian Patent Application No. 2005216898 (hide)

Owner The Penn State Research Foundation

Inventors Zagon, Ian S.; Smith, Jill P.; McLaughlin, Patricia J.

Agent Cullen & Co

Pub. Number AU-A-2005216898

PCT Pub. Number WO2005/082397

Priority 60/548,021 26.02.04 US

Filing date 21 February 2005

Wipo publication date 9 September 2005

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/082397 Priority application(s): WO2005/082397

20 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216904-Modulation of inflammatory and metastatic processes

2005216893-Closure device